AU3885900A - Inhibitors of the egf-receptor tyrosine kinase and their use - Google Patents

Inhibitors of the egf-receptor tyrosine kinase and their use

Info

Publication number
AU3885900A
AU3885900A AU38859/00A AU3885900A AU3885900A AU 3885900 A AU3885900 A AU 3885900A AU 38859/00 A AU38859/00 A AU 38859/00A AU 3885900 A AU3885900 A AU 3885900A AU 3885900 A AU3885900 A AU 3885900A
Authority
AU
Australia
Prior art keywords
egf
inhibitors
tyrosine kinase
receptor tyrosine
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38859/00A
Inventor
Sutapa Ghosh
Fatih M. Uckun
Yaguo Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Publication of AU3885900A publication Critical patent/AU3885900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
AU38859/00A 1999-03-19 2000-03-16 Inhibitors of the egf-receptor tyrosine kinase and their use Abandoned AU3885900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09273002 1999-03-19
US09/273,002 US6355678B1 (en) 1998-06-29 1999-03-19 Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
PCT/US2000/006807 WO2000056703A1 (en) 1999-03-19 2000-03-16 Inhibitors of the egf-receptor tyrosine kinase and their use

Publications (1)

Publication Number Publication Date
AU3885900A true AU3885900A (en) 2000-10-09

Family

ID=23042140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38859/00A Abandoned AU3885900A (en) 1999-03-19 2000-03-16 Inhibitors of the egf-receptor tyrosine kinase and their use

Country Status (5)

Country Link
US (2) US6355678B1 (en)
EP (1) EP1124795A1 (en)
AU (1) AU3885900A (en)
CA (1) CA2356816A1 (en)
WO (1) WO2000056703A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
DE10164711A1 (en) * 2001-03-13 2002-10-17 Schebo Biotech Ag Use of sugar phosphates, sugar phosphate analogs, amino acids and / or amino acid analogs for modulating the glycolysis-enzyme complex, the malate aspartate shuttle and / or the transaminases
GB0223854D0 (en) * 2002-10-12 2002-11-20 Astrazeneca Ab Therapeutic treatment
US20040147428A1 (en) * 2002-11-15 2004-07-29 Pluenneke John D. Methods of treatment using an inhibitor of epidermal growth factor receptor
EP1433779A1 (en) * 2002-12-23 2004-06-30 Jerini AG Use of nitriles as inhibitors of non-proteolytic enzymes
EP1493445A1 (en) * 2003-07-04 2005-01-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibition of stress-induced ligand-dependent EGFR activation
US7232824B2 (en) * 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
US8017321B2 (en) * 2004-01-23 2011-09-13 The Regents Of The University Of Colorado, A Body Corporate Gefitinib sensitivity-related gene expression and products and methods related thereto
GB0403744D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
AU2005249492B2 (en) 2004-05-27 2011-09-22 The Regents Of The University Of Colorado Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
CN101175492B (en) * 2005-03-11 2013-10-16 科罗拉多大学董事会 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors
CA2628219C (en) * 2005-11-01 2012-11-27 Rensselaer Polytechnic Institute Three-dimensional cellular array chip and platform for toxicology assays
US7820159B2 (en) * 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
JP2010509370A (en) * 2006-11-10 2010-03-25 シンダックス ファーマシューティカルズ，インク． Combination of ERα + ligand and histone deacetylase inhibitor for the treatment of cancer
WO2009067453A1 (en) * 2007-11-19 2009-05-28 Syndax Pharmaceuticals, Inc. Combinations of hdac inhibitors and proteasome inhibitors
AU2009234253C1 (en) * 2008-04-11 2015-05-07 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
WO2009147624A2 (en) * 2008-06-05 2009-12-10 Alembic Limited A process for preparing teriflunomide
JP5677972B2 (en) 2008-11-18 2015-02-25 メリマック ファーマシューティカルズ インコーポレーティッド Human serum albumin linker and its conjugates
WO2011014872A2 (en) * 2009-07-31 2011-02-03 The Johns Hopkins University Compositions and methods for diagnosing, treating or preventing neoplasias
US20150202287A1 (en) 2012-08-30 2015-07-23 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-erbb3 agents
CN102786437A (en) * 2012-09-06 2012-11-21 中国药科大学 Preparation method of teriflunomide
US20150224181A1 (en) 2012-09-14 2015-08-13 The United States Of America As Represented By The Secretary Department Of Health And Human Se Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
CN105272882B (en) * 2014-07-23 2019-05-31 欣凯医药化工中间体（上海）有限公司 A kind of easy method for preparing Tai Rui meter Te of environmental protection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (en) 1975-06-05 Hoechst Ag PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIFLOGISTICAL AND / OR ANALGETICAL ACTION AND PROCEDURE FOR THE PREPARATION OF A 2-HYDROXYETHYLIDE ENCYANAACETIC ANILIDE SUITABLE FOR USE IN THIS PROCESS.
DK545976A (en) 1975-12-11 1977-06-12 Hoechst Ag CYANACIC ACID ANILIDE DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND MEASURES CONTAINING THESE COMPOUNDS
US4346097A (en) 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (en) 1983-08-30 1985-04-24 Oreal COSMETIC OR PHARMACEUTICAL COMPOSITION IN AQUEOUS OR ANHYDROUS FORM WHOSE FATTY PHASE CONTAINS OLIGOMER POLYETHER AND NEW OLIGOMER POLYETHERS
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
DE59010701D1 (en) * 1990-05-18 1997-05-22 Hoechst Ag ISOXAZOLE-4-CARBONIC ACID AMIDES AND HYDROXYALKYLIDES-CYANACETIC ACID AMIDES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND THE USE THEREOF
IL99811A (en) 1990-10-30 1996-03-31 Roussel Uclaf 3-cycloalkyl-propanamides their tautomer forms and their salts preparation process and compositions containing them
DK0538783T3 (en) 1991-10-23 1996-02-05 Hoechst Ag N-Phenyl-2-cyano-3-hydroxycrotonic acid derivatives and their use in drugs with immunomodulatory properties
WO1994024095A1 (en) 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
DE19547648A1 (en) 1995-12-20 1997-06-26 Hoechst Ag Preparation containing high density lipoproteins and crotonic acid amide derivatives
DE19610955A1 (en) 1996-03-20 1997-09-25 Hoechst Ag Combination preparation containing 5-methylisoxazole-4-carboxylic acid- (4-trifluoromethyl) -anilide and N- (4-trifluoromethylphenyl) -2-cyano-3-hydroxycrotonic acid amide
DE19702988A1 (en) 1997-01-28 1998-07-30 Hoechst Ag Isoxazole and crotonic acid amide derivatives and their use as pharmaceuticals and diagnostics
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation

Also Published As

Publication number Publication date
US6355678B1 (en) 2002-03-12
EP1124795A1 (en) 2001-08-22
CA2356816A1 (en) 2000-09-28
US6864286B2 (en) 2005-03-08
US20020107284A1 (en) 2002-08-08
WO2000056703A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU3885900A (en) Inhibitors of the egf-receptor tyrosine kinase and their use
HK1026209A1 (en) Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
AU2728201A (en) 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
IL153246A0 (en) Substituted quinazoline derivatives and their use as inhibitors
AU2437900A (en) Piperidinylquinolines as protein tyrosine kinase inhibitors
AU4308397A (en) Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
AU1462101A (en) Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
HUP0300205A3 (en) Aurora 2 kinase inhibitor quinazoline derivatives, preparation and use thereof
IL148891A0 (en) Tyrosine kinase inhibitors
EP1161433A4 (en) Tyrosine kinase inhibitors
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
IL152115A0 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
AU2001270260A1 (en) 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
EE200100659A (en) Diaminothiazoles and their use for the inhibition of protein kinases
HK1049154A1 (en) 2-pyrazolin-5-ones as tyrosine kinase inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU3094197A (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same
AU2591299A (en) Human protein kinase c inhibitor
AU1456899A (en) Human protein kinase and kinase inhibitors
AU2001279090A1 (en) Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase